Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats

被引:17
作者
Baker, LE [1 ]
Pynnonen, D [1 ]
Poling, A [1 ]
机构
[1] Western Michigan Univ, Dept Psychol, Kalamazoo, MI 49008 USA
关键词
GHB; route of administration; reinforcement; drug discrimination; rats;
D O I
10.1007/s00213-003-1744-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale. Possible effects of reinforcer type on the results of drug discrimination studies have not been examined systematically, but different deprivation operations and differentially effective reinforcers might well influence outcomes. Objective. Therefore, this study examined the influence of reinforcer (food or water) as well as route of administration (IP or IG) on gamma-hydroxybutyrate (GHB) discrimination. Methods. Four separate groups of six rats were trained under a resetting fixed-ratio schedule to discriminate between 300 mg/kg GHB and vehicle under these conditions, then generalization tests were conducted with gamma-butyrolactone (GBL), 1,4-butanediol (1,4-BD), ethanol, and ethanol plus 150 mg/kg GHB. Results. Food maintained significantly higher response rates than water, but there were no significant differences among the four training groups in response accuracy or sessions required to meet the discrimination criterion. Training conditions significantly affected the results of stimulus generalization tests. The IG-Water group was most sensitive to a lower dose of GHB, and only the IP-Water group failed to generalize to orally-administered GHB. Gamma-butyrolactone and 1,4-butanediol fully substituted in all except the IP-Food group. Ethanol did not fully substitute for GHB in any group, and the combination of GHB (150 mg/kg) and ethanol did not have additive effects. Conclusions. These results demonstrate that methodological variables during drug discrimination training can certainly influence the results of stimulus generalization. Future investigations into the behavioral and/or physiological mechanisms that account for these effects are warranted.
引用
收藏
页码:220 / 227
页数:8
相关论文
共 19 条
[1]   Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination [J].
Baker, LE ;
Taylor, MM .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (04) :737-748
[2]   The role of GABAB receptors in the discriminative stimulus effects of γ-hydroxybutyrate in rats:: Time course and antagonism studies [J].
Carter, LP ;
Flores, LR ;
Wu, HF ;
Chen, WB ;
Unzeitig, AW ;
Coop, A ;
France, CP .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (02) :668-674
[3]   Involvement of GABAA and GABAB receptors in the mediation of discriminative stimulus effects of γ-hydroxybutyric acid [J].
Colombo, G ;
Agabio, R ;
Lobina, C ;
Reali, R ;
Gessa, GL .
PHYSIOLOGY & BEHAVIOR, 1998, 64 (03) :293-302
[4]   SYMMETRICAL GENERALIZATION BETWEEN THE DISCRIMINATIVE STIMULUS EFFECTS OF GAMMA-HYDROXYBUTYRIC ACID AND ETHANOL - OCCURRENCE WITHIN NARROW DOSE RANGES [J].
COLOMBO, G ;
AGABIO, R ;
LOBINA, C ;
REALI, R ;
FADDA, F ;
GESSA, GL .
PHYSIOLOGY & BEHAVIOR, 1995, 57 (01) :105-111
[5]   BLOCKADE OF THE DISCRIMINATIVE STIMULUS EFFECTS OF GAMMA-HYDROXYBUTYRIC ACID (GHB) BY THE GHB RECEPTOR ANTAGONIST NCS-382 [J].
COLOMBO, G ;
AGABIO, R ;
BOURGUIGNON, J ;
FADDA, F ;
LOBINA, C ;
MAITRE, M ;
REALI, R ;
SCHMITT, M ;
GESSA, GL .
PHYSIOLOGY & BEHAVIOR, 1995, 58 (03) :587-590
[6]  
EXTANCE K, 1981, PSYCHOPHARMACOLOGY, V91, P67
[7]   A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (±)-MDMA in rats [J].
Goodwin, AK ;
Baker, LE .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2000, 8 (03) :415-423
[8]   Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination [J].
Goodwin, AK ;
Pynnonen, DM ;
Baker, LE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 74 (04) :987-995
[9]   Contribution of GABAA and GABAB receptors to the discriminative stimulus produced by gamma-hydroxybutyric acid [J].
Lobina, C ;
Agabio, R ;
Reali, R ;
Gessa, GL ;
Colombo, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 64 (02) :363-365
[10]  
Makhay MM, 1998, EXP CLIN PSYCHOPHARM, V6, P3